COREPHARMA - Trademark Details
Status: 800 - Registered And Renewed
Image for trademark with serial number 77936220
Serial Number
77936220
Registration Number
3849981
Word Mark
COREPHARMA
Status
800 - Registered And Renewed
Status Date
2021-11-03
Filing Date
2010-02-16
Registration Number
3849981
Registration Date
2010-09-21
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2010-07-06
Attorney Name
Brian L. Petrequin, Esq.
Law Office Assigned Location Code
M30
Employee Name
FLOWERS, JAY K
Statements
Goods and Services
Pharmaceutical preparations for use in the treatment of respiratory disorders, gastrointestinal diseases, infectious diseases, cardiovascular disorders, neurological disorders, hyperlipidemia, pain and inflammation, musculoskeletal disorders, hormonal disorders, cancer, AIDS, Parkinson's disease, eating disorders and obesity, mental, emotional and anxiety disorders, diabetes, genitourinary disorders and nausea
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-02-19
Primary Code
005
First Use Anywhere Date
1998-07-13
First Use In Commerce Date
1998-07-13
Current Trademark Owners
Party Name
COREPHARMA, L.L.C.
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
COREPHARMA, L.L.C.
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
COREPHARMA, L.L.C.
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
COREPHARMA, L.L.C.
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
COREPHARMA, L.L.C.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration2351465
Trademark Events
Event DateEvent Description
2010-02-19NEW APPLICATION ENTERED IN TRAM
2010-02-19NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-05-19ASSIGNED TO EXAMINER
2010-05-19APPROVED FOR PUB - PRINCIPAL REGISTER
2010-06-02ASSIGNED TO LIE
2010-06-02LAW OFFICE PUBLICATION REVIEW COMPLETED
2010-07-06PUBLISHED FOR OPPOSITION
2010-07-06OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2010-09-21REGISTERED-PRINCIPAL REGISTER
2010-12-09ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2012-04-19TEAS CHANGE OF CORRESPONDENCE RECEIVED
2012-04-19TEAS CHANGE OF CORRESPONDENCE RECEIVED
2015-03-18ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2015-07-15ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2015-09-21COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2016-07-11TEAS SECTION 8 & 15 RECEIVED
2016-09-17CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2016-09-17REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2016-09-17NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
2019-09-21COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
2021-01-24TEAS SECTION 8 & 9 RECEIVED
2021-05-04CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2021-05-04POST REGISTRATION ACTION MAILED - SEC. 8 & 9
2021-11-02TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
2021-11-03REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2021-11-03REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2021-11-03NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED